Literature DB >> 12707242

Neurovascular dissociation with paradoxical forearm vasodilation during systemic tyramine administration.

Giris Jacob1, Fernando Costa, Simi Vincent, David Robertson, Italo Biaggioni.   

Abstract

BACKGROUND: Despite the widespread use of tyramine as a pharmacological tool to assess the effects of norepinephrine release from sympathetic nerve terminals, its vascular effects are not adequately characterized. In particular, previous results indicate that intravenous tyramine produces little if any systemic vasoconstriction, suggesting that tyramine does not cause significant norepinephrine release from sympathetic nerves innervating peripheral vascular beds. To test this hypothesis, we determined the effects of intravenous tyramine on local forearm norepinephrine spillover and vascular resistance. METHODS AND
RESULTS: Seven healthy subjects were studied with systemic and local forearm norepinephrine spillover and forearm blood flow at baseline, during systemic tyramine infusion, and after sympathetic stimulation induced by the cold pressor test. Tyramine infusion caused a significant increase in systemic and forearm norepinephrine spillover. The amount of norepinephrine released into the forearm by tyramine was similar to that caused by cold pressor stimulation, 0.15+/-0.05 versus 0.18+/-0.05 ng x dL(-1) x min(-1). As expected, forearm vascular resistance increased during the cold pressor test, but tyramine produced forearm vasodilation (4.5+/-1 versus -5+/-1 mm Hg x dL(-1) x min(-1), P<0.03) despite the increase in local norepinephrine spillover. In 6 additional subjects, plasma dopamine increased significantly during tyramine administration, from 11+/-3 to 662+/-105 pg/mL.
CONCLUSIONS: Thus, systemic tyramine infusion evokes a significant increase in peripheral norepinephrine spillover, and this, paradoxically, is associated with local vasodilatation rather than vasoconstriction.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2003        PMID: 12707242     DOI: 10.1161/01.CIR.0000065605.37863.C0

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  7 in total

1.  An investigation of components of variance and tachyphylaxis in a placebo-controlled intravenous tyramine study.

Authors:  M V Cantarini; C L Watkins; J Growcott; A M Hughes
Journal:  Br J Clin Pharmacol       Date:  2004-05       Impact factor: 4.335

2.  Dopamine contamination of infused tyramine.

Authors:  Courtney Holmes; Jeffrey Moak; Basil Eldadah; Ella Zimmerly; Yehonatan Sharabi; David S Goldstein
Journal:  Clin Chem       Date:  2005-07-21       Impact factor: 8.327

3.  Catecholamines 101.

Authors:  David S Goldstein
Journal:  Clin Auton Res       Date:  2010-07-11       Impact factor: 4.435

4.  Spontaneous atrial fibrillation initiated by tyramine in canine atria with increased sympathetic nerve sprouting.

Authors:  Ayaka Numata; Yasushi Miyauchi; Norihiko Ono; Michael C Fishbein; William J Mandel; Shien-Fong Lin; James N Weiss; Peng-Sheng Chen; Hrayr S Karagueuzian
Journal:  J Cardiovasc Electrophysiol       Date:  2011-10-28

5.  Generalized and neurotransmitter-selective noradrenergic denervation in Parkinson's disease with orthostatic hypotension.

Authors:  Yehonatan Sharabi; Richard Imrich; Courtney Holmes; Sandra Pechnik; David S Goldstein
Journal:  Mov Disord       Date:  2008-09-15       Impact factor: 10.338

6.  Functional effects of cardiac sympathetic denervation in neurogenic orthostatic hypotension.

Authors:  Richard Imrich; Basil A Eldadah; Oladi Bentho; Sandra Pechnik; Yehonatan Sharabi; Courtney Holmes; Ehud Grossman; David S Goldstein
Journal:  Parkinsonism Relat Disord       Date:  2008-05-29       Impact factor: 4.891

7.  Sex differences in the vascular response to sympathetic activation during acute hypoxaemia.

Authors:  Dain W Jacob; Jennifer L Harper; Clayton L Ivie; Elizabeth P Ott; Jacqueline K Limberg
Journal:  Exp Physiol       Date:  2021-07-10       Impact factor: 2.858

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.